Revolax Advantage Pack 5 Packs

Each syringe in the REVOLAX Advantage Pack contains 24 mg/ml of cross-linked, non-animal hyaluronic acid with 0.3 % lidocaine for patient comfort. The monophasic gel combines long and short HA chains in a single-phase matrix, providing strength and elasticity without excessive swelling.

This design allows for precise placement and smooth integration under facial movement, while the lidocaine diffuses quickly to reduce pain during injection. The cohesive gel structure resists breakdown for lasting results, and every syringe is sterilized and labeled for traceability under CE Class III rules.

Store between 2 °C and 25 °C to maintain product integrity. sample

REVOLAX Advantage Pack is designed for comprehensive facial correction—from fine lines around the lips to robust jawline definition. The pack includes three viscosities: Fine for superficial lines and lip borders, Deep for nasolabial folds and lip volume, and Sub-Q for structural augmentation in the chin, jawline, or nose.

Ideal for patients aged 25–65 seeking non-surgical facial enhancement. Contraindications include pregnancy, active skin conditions, autoimmune disorders, or lidocaine allergy.

Compared to some other fillers, REVOLAX maintains lift with less product per area thanks to its high elasticity. Results typically last 12–18 months for Deep and Sub-Q, and 9–12 months for Fine. s

Each Advantage Pack contains 5 sealed retail boxes. Every box includes:

1 x 1.1 ml prefilled glass syringe with color-coded plunger (blue for Fine, green for Deep, purple for Sub-Q)

2 sterile needles matched to the product's viscosity for optimal flow and safety

2 CE-marked traceability labels for patient files and clinic records

Instructions for Use leaflet detailing safe injection zones and post-treatment care

Packaging is tamper-evident and gamma-irradiated, with RFID tracking for anti-counterfeiting. Shelf life is 24 months when stored properly.

REVOLAX Advantage Pack offers results lasting 12–18 months for Deep and Sub-Q, and 9–12 months for Fine. High cross-link density ensures volume stability even in dynamic areas like the lips or jawline. Clinical studies show over 90 % of patients maintain noticeable improvement at 12 months, with many sustaining results at 18 months. MRI tracking confirms long-term presence of HA in treated areas. Lifestyle factors such as UV exposure, intense exercise, and smoking may shorten longevity. For best maintenance, schedule reviews at 9 months for active patients and 14–18 months for low-impact lifestyles.

Q1: Is REVOLAX Advantage Pack CE- or FDA-cleared?
A1: All syringes are CE Class III certified for medical use in Europe. The range is not FDA-cleared for the U.S.

Q2: How comfortable is the treatment?
A2: Built-in 0.3 % lidocaine reduces injection pain significantly. Sharp, thin-wall needles and smooth gel consistency make treatments highly tolerable, with average pain scores around 1.5 out of 10.

Q3: Can the results be dissolved if necessary?
A3: Yes. As a hyaluronic acid filler, REVOLAX can be safely dissolved with hyaluronidase, allowing corrections or adjustments as needed.

REVOLAX

REVOLAX Advantage Pack is produced by ACROSS Co., Ltd. in South Korea under ISO 13485-certified, GMP-compliant facilities. The proprietary cross-linking method eliminates free HA, delivering a cohesive gel with low swelling and high stability.

The company emphasizes sustainability with closed-loop water recycling, recyclable packaging with soy inks, and a syringe take-back program aimed at reducing medical plastic waste.

ACROSS also supports clinical education through the REVOLAX Academy, offering training in safe, effective injection techniques and funding research into long-term filler performance.

In short, the REVOLAX Advantage Pack gives clinics five syringes of reliable, CE-marked HA filler in three versatile viscosities, offering ergonomic delivery, long-lasting results, and responsible manufacturing for modern aesthetic practice.